SEC Filing Summary: Safety Shot, Inc. (8-K)
Business Context and Reporting Period
Company: Safety Shot, Inc. (Note: Input metadata referenced "BONK, INC.", but the filing text identifies the registrant as Safety Shot, Inc.)
Reporting Date: July 2, 2025
Exchange: The Nasdaq Capital Market (Ticker: SHOT, Warrants: SHOTW)
Status: Emerging Growth Company
Location: Jupiter, FL
This Current Report on Form 8-K discloses the entry into material definitive agreements, the unregistered sale of equity securities, and amendments to the Articles of Incorporation regarding the creation of Series B Preferred Stock.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. The document focuses on capital restructuring and debt-to-equity conversion.
- Debt Converted: $5,250,000 total principal amount of convertible notes exchanged for equity.
- Secured Convertible Note: $1,750,000 (Maturing Dec 31, 2026).
- Convertible Note: $3,500,000 (Maturing July 21, 2025).
- Equity Issued: 7,212 shares of Series B Convertible Preferred Stock issued in exchange for the notes above.
- Preferred Stock Terms:
- Stated Value: $750 per share.
- Conversion Price: $0.34 per share of Common Stock.
- Authorized Series B Shares: 10,000.
- Warrant Amendment: Exercise price for warrants held by two accredited investors reduced from $0.4348 to $0.33 per share.
Material Changes Versus Prior Period
The filing details specific transactions executed on July 2, 2025, rather than comparative period-over-period financial performance.
- Debt Reduction: Elimination of $5.25 million in outstanding convertible debt obligations through an exchange transaction.
- Capitalization Change: Creation of a new class of equity (Series B Preferred Stock) with voting and liquidation rights on an as-if-converted basis.
- Warrant Terms: Reduction in the exercise price of existing warrants, increasing their intrinsic value to holders.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, revenue outlook, or management discussion regarding future operations. The focus is strictly on the legal execution of the Exchange Agreement and the Amendment to the Securities Purchase Agreement.
Risks and Contingencies:
- Dilution Risk: The conversion of Series B Preferred Stock into Common Stock at $0.34 per share may result in significant dilution to existing common shareholders.
- Liquidity: The transaction involves unregistered sales of equity securities (Item 3.02), which may have restrictions on resale.
- Valuation Adjustments: The conversion price is subject to adjustment for stock dividends, splits, rights offerings, and fundamental transactions.
Key Facts for Investor Verification
- Verify the exact number of Common Shares that will be issued upon the full conversion of the 7,212 Series B Preferred shares (Calculated as: 7,212 shares * $750 / $0.34).
- Confirm the total outstanding share count of Common Stock to assess the immediate dilution impact of the Series B conversion.
- Review the full text of the Certificate of Designation (Exhibit 3.1) for specific limitations on conversion and voting rights not detailed in the summary.
- Check the status of the $3.5 million Convertible Note that was maturing on July 21, 2025, to ensure the exchange was finalized prior to maturity.
- Verify if the warrant price reduction to $0.33 triggers any anti-dilution provisions for other security holders.